A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension

NCT00635232 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: irbesartan
DRUG: placebo
DRUG: PS433540
DRUG: PS433540
DRUG: PS433540

Sponsor

Ligand Pharmaceuticals